Cardioquin

   
Google
 
Web NewDrugInformation.com

Cardioquin


Drug - Cardioquin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Quinidine Polygalacturonate
Multiple ingredients are in alphabetical order.

Strength - 275MG
The potency of the active ingredient(s), Quinidine Polygalacturonate. May repeat for multiple part products.

Applicant - PURDUE FREDERICK
The firm name holding legal responsibility for Cardioquin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011642
The FDA assigned number to Cardioquin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Cardioquin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Cardioquin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cardioquin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Cardioquin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Purdue Frederick Co
The full name of the firm holding legal responsibility for the new application of Cardioquin.

Cardioquin